“Giants of Cancer Care® award winners are helping to move the field of oncology forward through their commitment to innovative and groundbreaking contributions in cancer treatment and research." - Mike Hennessy Jr., pres., MJH Assoc.
Plainsboro, N.J. and New York, N.Y. (PRWEB) November 10, 2016
OncLive® is proud to announce the 2016 Giants of Cancer Care®, an esteemed group of 10 innovators in oncology research and clinical practice who have made landmark contributions to the field of oncology and set the stage for future advances. The winners were announced today at 11:35 a.m. and will be honored at tonight’s awards celebration from 5 to 7 p.m. at the New York Marriott Marquis, which is being held during the 34th Annual CFS Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®.
Now in its fourth year, the Giants of Cancer Care® campaign celebrates the achievements of leading physicians and researchers who have devoted their time, talent and resources to improving care for patients and their families affected by cancer. Recipients of the award demonstrate the qualities that distinguish them from others: unlimited selflessness, compassion for their patients and a desire to understand and develop life-changing treatments against a disease that affects so many.
“Giants of Cancer Care® award winners are helping to move the field of oncology forward through their commitment to innovative and groundbreaking contributions in cancer treatment and research. Our winners' achievements not only give cancer patients and their families hope, but they also inspire future generations of researchers and practitioners to continue advancing toward a cure for this disease,” says Michael Hennessy, Jr., president of Mike J. Hennessy Associates Inc., which produces OncLive®.
Nominated by the oncology community, all finalists are vetted by an elite five-member advisory board of world-renowned oncologists. The finalists in each category are then voted on by an 80+ member selection committee comprising the nation's leading physicians in the oncology space. The winners represent 10 categories: breast cancer, community outreach and education, gastrointestinal cancer, genitourinary cancer, hematologic malignancies, lung cancer, melanoma, radiation oncology, scientific advances and surgical oncology.
This year's award winners include:
Breast Cancer – Larry Norton, M.D., Memorial Sloan Kettering Cancer Center, New York, N.Y.
Community Outreach/Education – Joyce A. O’Shaughnessy, M.D., Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Tex.
Gastrointestinal Cancer – Daniel D. Von Hoff, M.D., Translational Genomics Research Institute, Phoenix, Ariz.
Genitourinary Cancer – Robert J. Motzer, M.D., Memorial Sloan Kettering Cancer Center, New York, N.Y.
Hematologic Malignancies – James F. Holland, M.D., Icahn School of Medicine at Mount Sinai, New York, N.Y.
Lung Cancer – Frances A. Shepherd, M.D., Princess Margaret Hospital, Toronto, Ontario, Can.
Melanoma – Jeffrey S. Weber, M.D., Ph.D., New York University Langone Medical Center, New York, N.Y.
Radiation Oncology – Samuel Hellman, M.D., University of Chicago, Chicago, Ill.
Scientific Advances – John Mendelsohn, M.D., The University of Texas MD Anderson Cancer Center, Houston, Tex.
Surgical Oncology – Sir Murray F. Brennan, M.D., Memorial Sloan Kettering Cancer Center, New York, N.Y.
According to the National Cancer Institute, almost 1.7 million new cases of cancer will be diagnosed in 2016, and nearly 600,000 people will die from the disease. However, the number of people living beyond a cancer diagnosis is rising and is expected to reach almost 19 million by 2024. Giants of Cancer Care® honorees are at the forefront of the battle against this disease.
The Giants of Cancer Care® program is overseen by an advisory board that includes its chairman Dr. Maurie Markman, from Cancer Treatment Centers of America, and members Dr. Patrick Borgen, Maimonides Hospital; Dr. George D. Demetri, Dana-Farber Cancer Institute/Harvard Cancer Center; Dr. Hope S. Rugo, University of California, San Francisco/Helen Diller Family Comprehensive Cancer Center; and Dr. Heather Wakelee, Stanford University Medical Center.
Every year for the past 33 years, the annual CFS Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® has brought together more than 2,000 oncologists, hematologists, radiation oncologists, immunologists, pharmacists, oncology nurses, nurse practitioners, physician assistants and case managers to learn about state-of-the-art treatments across solid and hematologic malignancies and diverse clinical scenarios. At the 34th Annual CFS Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®, leading clinical innovators in virtually every tumor subspecialty will continue to provide expert insights on new developments in cancer therapeutics.
Domestic and international nominations for the 2017 Giants of Cancer Care® are open now through March 20, 2017, and may be submitted online at http://www.giantsofcancercare.com/nominate. Self-nominations are permitted and encouraged. The Giants of Cancer Care® Advisory Board will determine finalists in each category, and a selection committee of more than 90 oncologists will vote to select the 2017 winners. The Class of 2017 Giants of Cancer Care® inductees will be announced in Chicago on June 1, 2017.
The 2016 Giants of Cancer Care® program was sponsored by Bayer Health Care, Merck, Puma Biotechnology, Incyte and Otsuka America Pharmaceutical Inc.
About OncLive®
OncLive® is a digital platform for practicing oncologists that offers oncology professionals information to help them provide the best patient care. OncLive.com is the official website for Michael J. Hennessy Associates Inc.'s Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News®, Oncology Business Management™ and more. Michael J. Hennessy Associates Inc. is a full-service health care communications company offering education, research, medical media, curetoday.com and CURE® magazine, the largest consumer publication focused entirely on cancer. CURE® combines science and humanity to make cancer understandable and reaches patients, cancer centers and advocacy groups.
###
Media inquiries:
For OncLive: Becky Taylor, 609-240-6886, becky(at)btaylorpa(dot)com